BENJO TAN: Open Payments
NPI 1841966249 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 34 payments from 9 companies in 2025. Trend: 2023 $920 · 2024 $1,139 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| ACADIA Pharmaceuticals Inc | 2 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| ABBVIE INC. | 6 | $139 |
| Neurocrine BioSciences, Inc. | 3 | $103 |
| Alkermes, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: NUPLAZID, AUSTEDO XR, VRAYLAR, INGREZZA, REXULTI, ARISTADA, COBENFY, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
